Briefly, MPH is beneficial in treating childhood ADHD while showing beneficial effects in early AD patients, which, following the current evidence, might be also due to its influence on the Wnt/mTOR-pathway. This evidence concerns the gene MTOR and attention deficit-hyperactivity disorder.